Finance

Lists
WAVE:CVE
Waverley Pharma Inc
CA$0.010
0.00%
(0.00) 1D
Oct 9, 11:21:02 AM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for WAVE...
Mkt. cap
540.00K
Avg. vol.
1.33K
Volume
0.00
52-wk high
CA$0.04
52-wk low
CA$0.01
EPS
-CA$0.01
Beta
0.45
Shares outstanding
54.00M
Mkt. cap
540.00K
Avg. vol.
1.33K
Volume
0.00
52-wk high
CA$0.04
52-wk low
CA$0.01
EPS
-CA$0.01
Beta
0.45
Shares outstanding
54.00M
News stories
From web sources and news partners
About Waverley Pharma Inc
CEO-
Employees-
Founded2014
HeadquartersWinnipeg, Manitoba, Canada
SectorBiotechnology
Websitewaverleypharma.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
275.66K
297.00K
287.13K
314.47K
Cost of goods sold
206.97K
178.23K
193.54K
202.42K
Cost of revenue
206.97K
178.23K
193.54K
202.42K
Research and development expenses
12.00K
350.00
-
1.09K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
245.00K
270.08K
216.44K
208.81K
Operating expense
256.99K
270.43K
216.44K
209.90K
Total operating expenses
463.96K
448.66K
409.98K
412.33K
Operating income
-188.30K
-151.66K
-122.85K
-97.86K
Other non operating income
-441.00
69.00
-30.00
-53.00
EBT including unusual items
-236.36K
-197.31K
-165.47K
-143.67K
EBT excluding unusual items
-236.36K
-197.31K
-165.47K
-143.67K
Income tax expense
1.63K
-
-
-
Effective tax rate
-0.69%
-
-
-
Other operating expenses
-
-
-
-
Net income
-237.99K
-197.31K
-165.47K
-143.67K
Net profit margin
-86.33%
-66.43%
-57.63%
-45.69%
Earnings per share
-
-
-
-
Interest and investment income
-
24.00
2.36K
-
Interest expense
-47.72K
-45.90K
-44.72K
-46.44K
Net interest expenses
-47.72K
-45.88K
-42.37K
-46.44K
Depreciation and amortization charges
-
-
-
-
EBITDA
-167.78K
-137.19K
-102.41K
-77.24K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps